Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant
Clinical trial NCT02032875 · COMPLETED
Trial details
- NCT number
- NCT02032875
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.